Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-27 @ 12:22 PM
Study NCT ID:
NCT06389292
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2024-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-05-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-26
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-24
First Submit QC Date:
None
Study First Post Date:
2024-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED